- Osteoarthritis — the forgotten obesity-related epidemic with worse to come [Letters] Margaret A Allman-Farinelli,
Robert J Aitken, Lesley A King and Adrian E Bauman
Med J Aust 2008; 188 (5): 317.
- On western health care [Book Review] Damien W Morgan
Med J Aust 2008; 188 (5): 275.
- Paying for costly pharmaceuticals: regulation of new drugs in Australia, England and New Zealand [Pharmaceuticals and Prescribing] James P Raftery
Med J Aust 2008; 188 (1): 26-28.
- The incidence and cost of adverse events in Victorian hospitals 2003–04 [Research] Jonathon P Ehsani, Terri Jackson and Stephen J Duckett
Med J Aust 2006; 184 (11): 551-555.
- The psychological health of sole mothers in Australia [Research] Deborah Loxton, Rosemary Mooney and Anne F Young
Med J Aust 2006; 184 (6): 265-268.
- Hospital in the home: what next? [Correction] Stephen F Wilson and Nicholas Collins
Med J Aust 2006; 184 (5): 237.
- Hospitalisation and costs attributable to tobacco smoking in Australia:
2001–2002 [Letters] Susan F Hurley
Med J Aust 2006; 184 (1): 45.
- Exploratory economic analyses of two primary care
mental health projects: implications for sustainability [Supplement: The Sustainability Of Primar] Cathrine Mihalopoulos, Litza Kiropoulos, Sophy T-F Shih, Jane Gunn, Grant Blashki and Graham Meadows
Med J Aust 2005; 183 (10 Suppl): S73-S76.
- A systematic review and economic analysis of drug-eluting coronary stents available in Australia [Systematic Review] Sarah J Lord, Kirsten Howard, Felicity Allen, Luke Marinovich, David C Burgess, Richard King and John J Atherton
Med J Aust 2005; 183 (9): 464-471.
- Cost-effectiveness of rehabilitation after an acute coronary event: a randomised controlled trial [Research] Tom G Briffa, Simon D Eckermann, Alison D Griffiths, Phillip J Harris, M Rose Heath, Saul B Freedman,
Lana T Donaldson, N Kathryn Briffa and Anthony C Keech
Med J Aust 2005; 183 (9): 450-455.
- General practice: who’s paying the piper? [Wish list] Robert W Pegram
Med J Aust 2005; 183 (2): 94.
- Short-term impact of smoking cessation on myocardial infarction and stroke hospitalisations and costs in Australia [Research] Susan F Hurley
Med J Aust 2005; 183 (1): 13-17.
- Cost-effectiveness of drug-eluting stents:
if only all things were equal [Editorials] Derek PB Chew
Med J Aust 2005; 182 (8): 376-377.
- Correction: The potential for tobacco control to reduce PBS costs for smoking-related cardiovascular disease [Correction] Susan F Hurley, Michelle M Scollo, Sandra J Younie, Dallas R English and Maurice G Swanson
Med J Aust 2004; 181 (10): 530.
- Making all data publicly available would be welcome [Matters Arising] Leonie Segal, Richard H Osborne and Susan E Day
Med J Aust 2004; 181 (6): 339-340.
- Cost-effectiveness findings not based on available evidence [Matters Arising] Chris G Fenn
Med J Aust 2004; 181 (6): 339-339.
- Can we reduce disease burden from osteoarthritis? [Matters Arising] Rosalie C Viney, Madeleine T King, Elizabeth J Savage and Jane P Hall || Leonie Segal, Richard H Osborne and Susan E Day || Chris G Fenn || Leonie Segal, Richard H Osborne and Susan E Day
Med J Aust 2004; 181 (6): 338-340.
- TTU is valuable for comparing disparate management options [Matters Arising] Leonie Segal, Richard H Osborne and Susan E Day
Med J Aust 2004; 181 (6): 338-339.
- Use of the TTU is questionable [Matters Arising] Rosalie C Viney, Madeleine T King, Elizabeth J Savage and Jane P Hall
Med J Aust 2004; 181 (6): 338-338.
- The potential for tobacco control to reduce PBS costs for smoking-related cardiovascular disease [Healthcare] Susan F Hurley, Michelle M Scollo, Sandra J Younie, Dallas R English and Maurice G Swanson
Med J Aust 2004; 181 (5): 252-255.
- How family physicians are funded in the United States [GP Funding — Viewpoint] Larry A Green
Med J Aust 2004; 181 (2): 113-114.
- How family physicians are funded in Canada [GP Funding — Viewpoint] Carmel M Martin and William E Hogg
Med J Aust 2004; 181 (2): 111-112.
- How general practice is funded in The Netherlands [GP Funding – Viewpoint] Chris Van Weel
Med J Aust 2004; 181 (2): 110-111.
- How general practice is funded in the United Kingdom [GP Funding – Viewpoints] David P Weller and Alan Maynard
Med J Aust 2004; 181 (2): 109-110.
- How general practice is funded in New Zealand [GP Funding — Viewpoints] Laurence A Malcolm
Med J Aust 2004; 181 (2): 106-107.
- Determinants of GP billing in Australia: content and time [GP Funding — Research] Helena Britt, Lisa Valenti, Graeme C Miller and Jillann Farmer
Med J Aust 2004; 181 (2): 100-104.
- How should GPs be paid? [GP Funding — Editorial] Chris Van Weel and Chris B Del Mar
Med J Aust 2004; 181 (2): 98-99.
- Olympic medals or long life: what’s the bottom line? [Letters] John Orchard and Caroline Finch || Craig R Mitton, H Dele Davies and Cam Donaldson
Med J Aust 2004; 180 (12): 655-656.
- Whose health service is it anyway? Community values in healthcare [ Viewpoint ] Gavin H Mooney and Scott H Blackwell
Med J Aust 2004; 180 (2) : 76-78.
- Olympic medals or long life: what’s the bottom line? [ Healthcare ] Craig R Mitton, H Dele Davies and Cam R Donaldson
Med J Aust 2004; 180 (2) : 71-73.
- There is such a thing as a
free lunch? [Letters] William Coote
Med J Aust 2003; 179 (11/12): 672.
- The PBS community awareness campaign:
how helpful is blaming patients? [Viewpoint] Evan Doran and David A Henry
Med J Aust 2003; 179 (10): 544-545.
- Public funding of large-scale clinical trials in Australia [Editorials] John J McNeil, Mark R Nelson and Andrew M Tonkin
Med J Aust 2003; 179 (10): 519-520.
- The destiny of general practice: blind fate or 20/20 vision? -General practice workforce [2020 Vision] William Coote
Med J Aust 2003; 179 (1): 48-49.
- Urinary incontinence in subacute care — a retrospective analysis
of clinical outcomes and costs [Healthcare] Janette P Green, Irenie Smoker, Maria Theresa Ho and Kate H Moore
Med J Aust 2003; 178 (11): 550-553.
- Doctors' perceptions and attitudes to prescribing within the
Authority Prescribing System [Research] Siaw-Teng Liaw, Christopher M Pearce, Patty Chondros, Barry P McGrath, Leone Piggford and Kay Jones
Med J Aust 2003; 178 (5): 203-206.
- In reply: Epidemiological modelling (including economic modelling) and its role in preventive drug therapy [Letters] Danny Liew, John J McNeil, Anna Peeters, Stephen S Lim and Theo Vos
Med J Aust 2003; 178 (4): 188-189.
- The decline in bulk-billing and increase in out-of-pocket costs for general practice consultations in rural areas of Aus [Healthcare] Anne F Young and Annette J Dobson
Med J Aust 2003; 178 (3): 122-126.
- Epidemiological modelling (including economic modelling) and its role in preventive drug therapy [Letters] Kent R Johnson and Marissa N Lassere
Med J Aust 2002; 178 (4): 188-189.
- Exceptional economic returns on investments
in medical research [The Research Enterprise] Leon E Rosenberg
Med J Aust 2002; 177 (7): 368-371.
- Epidemiological modelling (including economic modelling)
and its role in preventive drug therapy [Clinical update] Danny Liew, John J McNeil, Anna Peeters, Stephen S Lim and Theo Vos
Med J Aust 2002; 177 (7): 364-367.
- Cost analysis of ambulatory blood pressure monitoring in initiating antihypertensive drug treatment in Australian genera [Research] Ben Ewald and Brita Pekarsky
Med J Aust 2002; 176 (12): 580-583.
- Fundholding: learning from the past and looking to the future [Healthcare] Justin J Beilby and Brita Pekarsky
Med J Aust 2002; 176 (7): 321-325.
- PBS/RPBS cost implications
of trends and guideline recommendations in the pharmacological management of hypertension [Letters] Ben D Ewald and Brita Pekarsky
Med J Aust 2002; 176 (4): 189-190.
- PBS/RPBS cost implications of trends and guideline recommendations in the pharmacological management of hypertension [Letters] Ben D Ewald and Brita Pekarsky
Med J Aust 2002; 176 (4): 189-190.
- The why and the wherefore [GP Corporatisation] Barry R Catchlove
Med J Aust 2001; 175: 68-70
- Economic costs of urinary incontinence in community-dwelling Australian women [Medicine and the Community] Christopher M Doran, Pauline Chiarelli and Jill Cockburn
Med J Aust 2001; 174: 456-458
- The costs of urinary incontinence [Editorial] Kate H Moore
Med J Aust 2001; 174: 436-437
- Economic sanctions and public health: the case of Iraq [Viewpoint] Susan J Wareham
Med J Aust 2000; 173: 438-439
- A randomised crossover trial of chemotherapy in the home: patient preferences and cost analysis [Research] Danny Rischin, Michelle A White, Jane P Matthews, Guy C Toner, Kathryn Watty, Anthony J Sulkowski, Jan L Clarke and Lois Buchanan
Med J Aust 2000; 173: 125-127
- Medicare: diagnosis and prognosis [Looking Forward] Frances C Cunningham
Med J Aust 2000; 173: 52-55
- The future of Medicare and health service financing [Looking Forward] Stephen R Leeder and Ian A McAuley
Med J Aust 2000; 173: 48-51
- Medicare's maturity: shaping the future from the past [Looking Forward] John S Deeble
Med J Aust 2000; 173: 44-47
- Medicare: options for the next 25 years [Looking Foward] Richard B Scotton
Med J Aust 2000; 173: 41-43
- Medibank: from conception to delivery and beyond [Looking Back] Richard B Scotton
Med J Aust 2000; 173: 9-11
- Reconciliation, social equity and Indigenous health [Editorial] Sandra J Eades
Med J Aust 2000; 172: 468-469
- Open invitation from the International Poverty and Health Network to all healthcare professionals [Editorials] Iona Heath, Andy Haines, John Glover and Diana Hetzel
Med J Aust 2000; 172: 356-357
- Funding Australia's basic biomedical research of 1993 and 1994 [The Research Enterprise] Linda Butler
Med J Aust 1999; 171: 629-633
- Hepatitis C: an economic evaluation of extended treatment with interferon [Healthcare] Alan Shiell, Sue Brown and Geoff C Farrell
Med J Aust 1999; 171: 189-193
- APPENDIX 1 Treatment episode costs Alan Shiell, Sue Brown, Geoff C Farrell
Med J Aust 1999; 171: 189-193
- Ethical implications of competition policy in healthcare [Ethics] Paul A Komesaroff
Med J Aust 1999; 170: 266-268
- Rethinking the early childcare agenda [Viewpoint] Peter S Cook
Med J Aust 1999; 170: 29-31
- Teaching and research in a casemix funding environment [Casemix supplement] Paddy A Phillips
Med J Aust 1998; 169: S53-S55
- The surgeon and casemix [Casemix supplement] John A L Hart and David Wallace
Med J Aust 1998; 169: S51-S52
- Casemix perspectives for clinicians in the private sector [Casemix supplement] Chris N Maxwell
Med J Aust 1998; 169: S48-S50
- Casemix: the allied health response [Casemix supplement] F McCathie
Med J Aust 1998; 169: S46-S47
- Casemix: challenges for nursing care [Casemix supplement] Lesley E Long and Rosemary Mann
Med J Aust 1998; 169: S44-S45
- Transferred patients - more complex and more costly? [Casemix supplement] Warwick W Butt and Frank A Shann
Med J Aust 1998; 169: S42-S43
- The true cost of treating children [Casemix supplement] Ralph M Hanson, Meradith A Phythian, Jenni B Jarvis and Cyndy Stewart
Med J Aust 1998; 169: S39-S41
- DRG cost weights - getting it right [Casemix supplement] Peter D Phelan, Richard Tate, Fiona Webster and Ric P Marshall
Med J Aust 1998; 169: S36-S38
- Introducing ICD-10-AM in Australian hospitals [Casemix supplement] Rosemary F Roberts, Kerry C Innes and Susan M Walker
Med J Aust 1998; 169: S32-S35
- Outpatient costing and classification: are we any closer to a national standard for ambulatory classification systems? [Casemix supplement] Michael I Cleary, Jo M Murray, Robin Michael and Kym Piper
Med J Aust 1998; 169: S26-S31
- Subacute and non-acute casemix in Australia [Casemix supplement] Lynette A Lee, Kathy M Eagar and Michael C Smith
Med J Aust 1998; 169: S22-S25
- Casemix funding for acute hospital inpatient services in Australia [Casemix supplement] Stephen J Duckett
Med J Aust 1998; 169: S17-S21
- The Aboriginal and Torres Strait Islander Casemix Study [Casemix supplement] Dale A Fisher, Jo M Murray, Michael I Cleary and Rita E Brewerton
Med J Aust 1998; 169: S11-S16
- The casemix system of hospital funding can further disadvantage Aboriginal children [Casemix supplement] Alan R Ruben and Dale A Fisher
Med J Aust 1998; 169: S6-S10
- Funding Australia's health and medical research [The research enterprise] Warwick P Anderson
Med J Aust 1997; 167: 608-609
- Teaching and research in a casemix funding environment [Casemix supplement] Paddy A Phillips
1998; 169: S53-S55
- The surgeon and casemix [Casemix supplement] John A L Hart and David Wallace
1998; 169: S51-S52
- Casemix perspectives for clinicians in the private sector [Casemix supplement] Chris N Maxwell
1998; 169: S48-S50
- Casemix: the allied health response [Casemix supplement] F McCathie
1998; 169: S46-S47
- Casemix: challenges for nursing care [Casemix supplement] Lesley E Long and Rosemary Mann
1998; 169: S44-S45
- Transferred patients - more complex and more costly? [Casemix supplement] Warwick W Butt and Frank A Shann
1998; 169: S42-S43
- The true cost of treating children [Casemix supplement] Ralph M Hanson, Meradith A Phythian, Jenni B Jarvis and Cyndy Stewart
1998; 169: S39-S41
- DRG cost weights - getting it right [Casemix supplement] Peter D Phelan, Richard Tate, Fiona Webster and Ric P Marshall
1998; 169: S36-S38
- Introducing ICD-10-AM in Australian hospitals [Casemix supplement] Rosemary F Roberts, Kerry C Innes and Susan M Walker
1998; 169: S32-S35
- Outpatient costing and classification: are we any closer to a national standard for ambulatory classification systems? [Casemix supplement] Michael I Cleary, Jo M Murray, Robin Michael and Kym Piper
1998; 169: S26-S31
- Subacute and non-acute casemix in Australia [Casemix supplement] Lynette A Lee, Kathy M Eagar and Michael C Smith
1998; 169: S22-S25
- Casemix funding for acute hospital inpatient services in Australia [Casemix supplement] Stephen J Duckett
1998; 169: S17-S21
- The Aboriginal and Torres Strait Islander Casemix Study [Casemix supplement] Dale A Fisher, Jo M Murray, Michael I Cleary and Rita E Brewerton
1998; 169: S11-S16
- The casemix system of hospital funding can further disadvantage Aboriginal children [Casemix supplement] Alan R Ruben and Dale A Fisher
1998; 169: S6-S10